B. Riley Predicts ZimVie’s Q1 Earnings (NASDAQ:ZIMV)

ZimVie Inc. (NASDAQ:ZIMV) – B. Riley issued their Q1 2025 earnings per share (EPS) estimates for shares of ZimVie in a research note issued to investors on Wednesday, April 9th. B. Riley analyst A. Schock forecasts that the company will earn ($0.01) per share for the quarter. B. Riley currently has a “Strong-Buy” rating on the stock. The consensus estimate for ZimVie’s current full-year earnings is $0.60 per share. B. Riley also issued estimates for ZimVie’s Q2 2025 earnings at ($0.02) EPS, Q3 2025 earnings at ($0.08) EPS, Q4 2025 earnings at $0.01 EPS, FY2025 earnings at ($0.10) EPS, Q1 2026 earnings at $0.02 EPS, Q2 2026 earnings at $0.07 EPS, Q3 2026 earnings at $0.01 EPS, Q4 2026 earnings at $0.12 EPS and FY2026 earnings at $0.22 EPS.

ZimVie (NASDAQ:ZIMV) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.02. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. The business had revenue of $111.52 million for the quarter, compared to analysts’ expectations of $113.67 million.

Separately, Needham & Company LLC reiterated a “hold” rating on shares of ZimVie in a report on Wednesday, April 9th.

ZimVie Trading Up 3.2 %

Shares of ZIMV opened at $9.44 on Monday. ZimVie has a twelve month low of $8.56 and a twelve month high of $22.40. The firm has a market capitalization of $262.88 million, a P/E ratio of -0.72 and a beta of 2.14. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57. The stock’s fifty day simple moving average is $11.88 and its 200 day simple moving average is $13.44.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. J. Goldman & Co LP raised its stake in shares of ZimVie by 167.5% in the 4th quarter. J. Goldman & Co LP now owns 1,425,810 shares of the company’s stock valued at $19,890,000 after purchasing an additional 892,785 shares in the last quarter. American Century Companies Inc. lifted its holdings in ZimVie by 23.9% during the 4th quarter. American Century Companies Inc. now owns 628,050 shares of the company’s stock worth $8,761,000 after buying an additional 121,053 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of ZimVie by 9.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,244,938 shares of the company’s stock worth $17,367,000 after acquiring an additional 107,461 shares in the last quarter. Mill Road Capital Management LLC bought a new stake in shares of ZimVie in the 4th quarter valued at approximately $1,401,000. Finally, Ancora Advisors LLC raised its position in shares of ZimVie by 460.8% during the 4th quarter. Ancora Advisors LLC now owns 112,160 shares of the company’s stock valued at $1,565,000 after acquiring an additional 92,160 shares in the last quarter. 95.63% of the stock is currently owned by institutional investors.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.